Drugs / Sal
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00455923 | May 2005 → Jul 2007 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sal | “50/100 mcg Seretide (combination of Sal/FP) via Diskus inhaler” NCT00455923 ↗ |
| Route | Inhaled | “50/100 mcg Seretide (combination of Sal/FP) via Diskus inhaler” NCT00455923 ↗ |